Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by TAKAMORI, M.
Right arrow Articles by TSUJIHATA, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by TAKAMORI, M.
Right arrow Articles by TSUJIHATA, M.
NEUROLOGY 1978;28:603
© 1978 American Academy of Neurology

Active state properties ofdenervated and immobilized muscle

Comparison with dystrophic muscle

MASAHARU TAKAMORI, M.D., RYUJI HAZAMA, M.D. and MlTSUHlRO TSUJIHATA, M.D.

First Department of Internal Medicine, Nagasaki University School of Medicine, 7-1, Sakamoto-machi. Nagasaki, Japan.

Possible roles of neurotrophic mechanisms and muscle activity in the contractile abnormalities of muscular dystrophy were studied by comparing human dystrophic muscle to denervated and immobilized muscle. As evident in denervated muscle from the decreased acceleration of twitch development (decreased active state intensity of shortening), and isoproterenol-induced decrease of twitch with shortened decay of the active state, part of the abnormality in the subcellular calcium transport system in dystrophic muscle seems to be influenced by disordered neural regulation. Other active state abnormalities relating to activation processes and contractile proteins in dystrophic muscle were also demonstrated in both denervated and immobilized muscle, with some being more marked in immobilized muscle. The findings indicate that a neurogenic hypothesis cannot entirely explain the pathogenesis of progressive muscular dystrophy.

Reprint requests should be addressed to Dr. Takamori, First Department of Internal Medicine, Nagasaki University School of Medicine, 7-1, Sakamoto-machi. Nagasaki, Japan.

Presented in part at the Fifth International Scientific Conference of the Muscular Dystrophy Association, Durango, Colorado, June 1976.

Accepted for publication December 13, 1977.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1978 by AAN Enterprises, Inc.